fbpx
September 11, 2023

Night Owls Have Higher Risk of Developing Type 2 Diabetes Night Owls Have Higher Risk of Developing Type 2 Diabetes

“Night owls” have an increased risk for developing type 2 diabetes and are more likely to smoke more, exercise less, and have poor sleep habits compared […]
September 11, 2023

AI Mammogram Screening Is Equivalent to Human Readers AI Mammogram Screening Is Equivalent to Human Readers

With the advent of artificial intelligence (AI), the era of double reading of mammograms is likely coming to a close, according to Liane Philpotts, MD, a radiology […]
September 11, 2023

Can Skin Bleaching Lead to Cancer? Can Skin Bleaching Lead to Cancer?

SINGAPORE — Can the prolonged use of skin-lightening products, such as hydroquinone, lead to skin cancer? This question was posed by Ousmane Faye, MD, PhD, director […]
September 11, 2023

New COVID Vaccines Force Bivalents Out­ New COVID Vaccines Force Bivalents Out­

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. COVID vaccines will have a new formulation this year, according to a […]
September 11, 2023

Using JAK Inhibitors for Myelofibrosis Using JAK Inhibitors for Myelofibrosis

Despite a growing list of Janus kinase (JAK) inhibitors, ruxolitinib remains the go-to for patients with symptomatic, higher risk myelofibrosis, according to Anthony M. Hunter, MD, a […]
September 11, 2023

‘Promising’ New Txs for Most Common Adult Leukemia ‘Promising’ New Txs for Most Common Adult Leukemia

The rapid rise of chimeric antigen receptor T (CAR T-cell) therapy has allowed hematologists to make great strides in treating aggressive cases of multiple myeloma and […]
September 11, 2023

Sleep Apnea Diagnosis: Awareness and Tools Sleep Apnea Diagnosis: Awareness and Tools

Obstructive sleep apnea (OSA) remains a significantly underdiagnosed condition, despite its high prevalence. Primary care physicians play a pivotal role in identifying patients afflicted by this […]
September 11, 2023

Novel ADC Offers Hope in Heavily Pretreated NSCLC Novel ADC Offers Hope in Heavily Pretreated NSCLC

SINGAPORE — Heavily pretreated patients with EGFR-mutated non–small cell lung cancer (NSCLC) may experience a clinically meaningful benefit with the antibody-drug conjugate (ADC) patritumab deruxtecan (HER3-DXd), […]
September 11, 2023

Frequency and Duration of GERD Associated With Poor Sleep Frequency and Duration of GERD Associated With Poor Sleep

Gastroesophageal reflux symptoms in women may increase the risk of poor sleep quality, shows a recent analysis of the Nurses’ Health Study II published in JAMA Network […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930931932933934935936937938939940941942943944945
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0